Matthew D Ringel

Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro.

Bon Seok Koo, Kyle Porter, David Jarjoura, 2012, Endocrine-related cancer.

Discovery of common variants associated with low TSH levels and thyroid cancer risk

Kari Stefansson, Gudmar Thorleifsson, Jon Hrafnkelsson, 2012, Nature Genetics.

Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.

Charis Eng, Andrea Frilling, Frank Weber, 2005, The Journal of clinical endocrinology and metabolism.

A genome-wide association study yields five novel thyroid cancer risk loci

Sandya Liyanarachchi, Kari Stefansson, Gudmar Thorleifsson, 2017, Nature Communications.

Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.

Dirk Schadendorf, Thomas Hielscher, Dieter Weichenhan, 2011, Carcinogenesis.

Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.

Jean Gaudart, J. Gaudart, V. Vasko, 2004, European journal of endocrinology.

Phase II trial of sorafenib in metastatic thyroid cancer.

Jiachao Liang, Michael V Knopp, Lai Wei, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.